Quick Takeaways
- This page summarizes Robert E. Waltermire's Form 4 filing for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 23 May 2024, 21:36.
Robert E. Waltermire - 21 May 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)
- Signature
- /s/ Mardi Dier, as Attorney-in-Fact**
- Issuer symbol
- MDGL
- Transactions as of
- 21 May 2024
- Net transactions value
- -$239,668
- Form type
- 4
- Filing time
- 23 May 2024, 21:36:56 UTC
- Previous filing
- 25 Jan 2024
- Next filing
- 14 Jun 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Robert E. Waltermire filed Form 4 for MADRIGAL PHARMACEUTICALS, INC. (MDGL) on 23 May 2024."
What Changed
- Previous filing in this sequence was filed on 25 Jan 2024.
- Current net transaction value: -$239,668.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDGL | Common Stock | Sale | $239,668 | -1,036 | -16% | $231.34 | 5,500 | 21 May 2024 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
Exhibit 24 - Power of Attorney